Skip to content

Study · In vitro (cells) · 1981

1 result

Thymosin beta 3 and beta 4

GOLDSTEIN ALLAN L, LOW TERESA L K

Journal not recorded16 Jun 1980

PepBankPUB-90739085
Source linkAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Activity measurement

    In T-cell populations, thymosin beta‑4 (with thymosin beta 3) induced terminal deoxynucleotidyl transferase (TdT) positive cells.

    In plain wordsIn lab tests, thymosin beta‑4 and the related thymosin beta 3 raised the number of TdT-positive T cells.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    IncreaseInduction of TdT-positive cells in T-cell populations
    Study

    n: not reported in source

    T-cell populations
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The compounds have useful biological activity as evidenced by their ability to induce terminal deoxynucleotidyl transferase (TdT) positive cells in T-cell populations.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.